Caribou Biosciences, Inc.

The momentum for this stock is not very good. Caribou Biosciences, Inc. is not a good value stock. Tradey thinks it is not wise to invest in Caribou Biosciences, Inc..
Log in to see more information.

News

Candriam S.C.A. Sells 520,000 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)
Candriam S.C.A. Sells 520,000 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)

Zolmax Candriam S.C.A. reduced its stake in Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 45.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities...\n more…

Here's Why We're Watching Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation
Here's Why We're Watching Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation

Simply Wall St Just because a business does not make any money, does not mean that the stock will go down. For example, although...\n more…

Caribou Biosciences (NASDAQ:CRBU) Stock Rating Reaffirmed by HC Wainwright
Caribou Biosciences (NASDAQ:CRBU) Stock Rating Reaffirmed by HC Wainwright

Ticker Report Caribou Biosciences (NASDAQ:CRBU - Get Free Report)s stock had its "buy" rating reaffirmed by research analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They...\n more…

Truist Financial Reaffirms Their Buy Rating on Caribou Biosciences (CRBU)
Truist Financial Reaffirms Their Buy Rating on Caribou Biosciences (CRBU)

TipRanks Financial Blog Truist Financial analyst Jailendra Singh reiterated a Buy rating on Caribou Biosciences (CRBU - Research Report) today. The company's shares closed...\n more…

Caribou Biosciences CFO Jason O'Byrne resigns
Caribou Biosciences CFO Jason O'Byrne resigns

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Caribou Biosciences (CRBU) Receives a Buy from H.C. Wainwright
Caribou Biosciences (CRBU) Receives a Buy from H.C. Wainwright

TipRanks Financial Blog H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Caribou Biosciences (CRBU - Research Report) today and set a price target of $9.00....\n more…